NCT05052723 2025-11-19Cabozantinib and Pembrolizumab in Metastatic PancreasUniversity of KentuckyPhase 2 Completed21 enrolled 12 charts
NCT04400474 2025-06-19CABATENGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed93 enrolled 17 charts